Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 26;22(23):12800.
doi: 10.3390/ijms222312800.

Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19

Affiliations
Review

Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19

Tomas Rajtik et al. Int J Mol Sci. .

Abstract

Alternative branches of the classical renin-angiotensin-aldosterone system (RAS) represent an important cascade in which angiotensin 2 (AngII) undergoes cleavage via the action of the angiotensin-converting enzyme 2 (ACE2) with subsequent production of Ang(1-7) and other related metabolites eliciting its effects via Mas receptor activation. Generally, this branch of the RAS system is described as its non-canonical alternative arm with counterbalancing actions to the classical RAS, conveying vasodilation, anti-inflammatory, anti-remodeling and anti-proliferative effects. The implication of this branch was proposed for many different diseases, ranging from acute cardiovascular conditions, through chronic respiratory diseases to cancer, nonetheless, hypoxia is one of the most prominent common factors discussed in conjugation with the changes in the activity of alternative RAS branches. The aim of this review is to bring complex insights into the mechanisms behind the various forms of hypoxic insults on the activity of alternative RAS branches based on the different duration of stimuli and causes (acute vs. intermittent vs. chronic), localization and tissue (heart vs. vessels vs. lungs) and clinical relevance of studied phenomenon (experimental vs. clinical condition). Moreover, we provide novel insights into the future strategies utilizing the alternative RAS as a diagnostic tool as well as a promising pharmacological target in serious hypoxia-associated cardiovascular and cardiopulmonary diseases.

Keywords: angiotensin(1-7); angiotensin-converting enzyme 2; hypoxia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
RAS cleavage cascade and the principal receptors of Ang II and Ang(1-7).
Figure 2
Figure 2
Selected molecular pathways affected by ACE2/Ang(1-7)/Mas axis in cardiovascular and pulmonary systems.
Figure 3
Figure 3
The main conclusions of the overall ACE2/Ang(1-7)/Mas axis activity in cardiovascular and pulmonary hypoxic conditions.

Similar articles

Cited by

References

    1. Simko F., Hrenak J., Adamcova M., Paulis L. Renin-Angiotensin-Aldosterone System: Friend or Foe-The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions. Int. J. Mol. Sci. 2021;22:3217. doi: 10.3390/ijms22063217. - DOI - PMC - PubMed
    1. Forrester S.J., Booz G.W., Sigmund C.D., Coffman T.M., Kawai T., Rizzo V., Scalia R., Eguchi S. Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology. Physiol. Rev. 2018;98:1627–1738. doi: 10.1152/physrev.00038.2017. - DOI - PMC - PubMed
    1. Sampaio W.O., Souza dos Santos R.A., Faria-Silva R., da Mata Machado L.T., Schiffrin E.L., Touyz R.M. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension. 2007;49:185–192. doi: 10.1161/01.HYP.0000251865.35728.2f. - DOI - PubMed
    1. Zhang F., Xu Y., Pan Y., Sun S., Chen A., Li P., Bao C., Wang J., Tang H., Han Y. Effects of Angiotensin-(1-7) and Angiotensin II on Acetylcholine-Induced Vascular Relaxation in Spontaneously Hypertensive Rats. Oxid. Med. Cell Longev. 2019;2019:6512485. doi: 10.1155/2019/6512485. - DOI - PMC - PubMed
    1. Zhang F., Ren X., Zhao M., Zhou B., Han Y. Angiotensin-(1-7) abrogates angiotensin II-induced proliferation, migration and inflammation in VSMCs through inactivation of ROS-mediated PI3K/Akt and MAPK/ERK signaling pathways. Sci. Rep. 2016;6:34621. doi: 10.1038/srep34621. - DOI - PMC - PubMed